Online crowd-sourcing – in which a task is presented to the public, who respond, for free, with various solutions and suggestions – has been used to evaluate potential consumer products, develop software algorithms and solve vexing research-and-develop…
An online report in Malaria Journal reveals that scientists have discovered genetic mutations in the deadliest malaria parasite in Africa that makes them resistant to one of the most powerful anti-malarial drugs. The researchers point out that the find…
Since the 1930s, there have been 75 documented episodes of malaria resurgence worldwide, most of which were linked to weakening of malaria control programs, finds a new study published in BioMed Central’s open access journal Malaria Journal. The study,…
In the first experiment of its kind to test the suggestion that hookworm infection can reduce some allergic responses, a UK doctor who specializes in medical entomology, infected himself with the parasite and then swallowed a pill camera to film the…
A team of scientists from the University of North Carolina at Chapel Hill and Vanderbilt University have pinpointed the region on dengue virus that is neutralized in people who overcome infection with the deadly pathogen. The results challenge the curr…
Researchers from the University of Notre Dame’s Eck Institute for Global Health developed a “gene chip” to contribute to the identification of malaria drug resistance, an effort that will allow for real-time response in modified treatment strategies fo…
After extensive reports of a malaria resistant strain to standard artemisinin treatment along the Cambodia-Thailand border, a new study published Online First in The Lancet informs that the resistant type of malaria has emerged and is rapidly increasi…
Researchers have identified enzymes and biochemical compounds called lipids that are targeted and modified by the dengue virus during infection, suggesting a potential new approach to control the aggressive mosquito-borne pathogen. Findings also sugges…
The prospect of deep cuts in the federal budget threatens to reverse the dramatic progress of a bipartisan US commitment to defeat neglected diseases in developing countries, according to a new report releases by the Global Health Technologies Coalitio…
The Infectious Disease Research Institute (IDRI) has launched the first human trial of a new vaccine for Visceral Leishmaniasis (VL). The trial is being conducted in Washington State, and a Phase 1 trial is planned in India, where VL is prevalent. The…
